相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600E inhibitors
Eslam M. H. Ali et al.
BIOORGANIC CHEMISTRY (2021)
Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor
Eslam M. H. Ali et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAFV600E/p38α inhibitors
Eslam M. H. Ali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Insights into new mechanisms and models of cancer stem cell multidrug resistance
Y. Garcia-Mayea et al.
SEMINARS IN CANCER BIOLOGY (2020)
Recent advances in isatin hybrids as potential anticancer agents
Zhen Ding et al.
ARCHIV DER PHARMAZIE (2020)
Novel cyanoacetamide integrated phenothiazines: Synthesis, characterization, computational studies and in vitro antioxidant and anticancer evaluations
Kannan Gokula Krishnan et al.
JOURNAL OF MOLECULAR STRUCTURE (2020)
Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?
Rana El Rawas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
History of global burden of disease assessment at the World Health Organization
Colin D. Mathers
ARCHIVES OF PUBLIC HEALTH (2020)
Tetrazole hybrids with potential anticancer activity
Jingyu Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Targeting ERK1/2 protein-serine/threonine kinases in human cancers
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Indole: A privileged scaffold for the design of anti-cancer agents
Yichao Wan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Polytherapy and Targeted Cancer Drug Resistance
Nilanjana Chatterjee et al.
TRENDS IN CANCER (2019)
Synthesis and molecular docking study of new benzofuran and furo[3,2-g]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors
Kamelia M. Amin et al.
BIOORGANIC CHEMISTRY (2018)
Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
Sukru Aydin Duzgun et al.
CYTOTECHNOLOGY (2017)
Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
Jacob R. Haling et al.
CANCER CELL (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
BRAF Mutations in Hairy-Cell Leukemia
Enrico Tiacci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation
Ryan B. Corcoran et al.
SCIENCE SIGNALING (2010)
Regulatory mechanisms of mitogen-activated kinase signaling
Y. Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
P38 MAP-Kinases pathway regulation, function and role in human diseases
Ana Cuenda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Role of MAPKs in development and differentiation: lessons from knockout mice
M. Aouadi et al.
BIOCHIMIE (2006)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
Mitogen-activated protein kinases in apoptosis regulation
T Wada et al.
ONCOGENE (2004)
The p38 signal transduction pathway - Activation and function
K Ono et al.
CELLULAR SIGNALLING (2000)
分享论文
